Central Nervous System Stimulant [EPC]

Central Nervous System Stimulant [EPC] was reported 87385 times

These side effects are most commonly reported by patients taking drugs of the Central Nervous System Stimulant [EPC] class:

# Drug class Count
0 DRUG INEFFECTIVE 11102
1 OFF LABEL USE 9069
2 NO ADVERSE EVENT 7084
3 PRODUCT QUALITY ISSUE 5935
4 HEADACHE 5716
5 NAUSEA 5285
6 PRODUCT USE IN UNAPPROVED INDICATION 5139
7 FATIGUE 5113
8 TOXICITY TO VARIOUS AGENTS 4232
9 PAIN 4039
10 DIZZINESS 3477
11 ANXIETY 3415
12 VOMITING 3408
13 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3369
14 INSOMNIA 3119
15 DIARRHOEA 3101
16 DYSPNOEA 3062
17 CONDITION AGGRAVATED 2751
18 ARTHRALGIA 2607
19 MALAISE 2550
20 DECREASED APPETITE 2530
21 DRUG ABUSE 2530
22 DEPRESSION 2438
23 MIGRAINE 2437
24 RASH 2392
25 ABDOMINAL PAIN UPPER 2377
26 HYPERTENSION 2339
27 ABDOMINAL DISCOMFORT 2251
28 OVERDOSE 2229
29 ASTHENIA 2228
30 PYREXIA 2142
31 PRURITUS 2114
32 WEIGHT INCREASED 2078
33 DRUG ADMINISTRATION ERROR 2068
34 CONFUSIONAL STATE 2051
35 FALL 2034
36 WEIGHT DECREASED 1962
37 SOMNOLENCE 1951
38 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1896
39 FEELING ABNORMAL 1866
40 CHEST PAIN 1855
41 APPLICATION SITE ERYTHEMA 1850
42 HYPERSENSITIVITY 1846
43 ALOPECIA 1836
44 DRUG DOSE OMISSION 1826
45 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1794
46 NASOPHARYNGITIS 1767
47 SINUSITIS 1737
48 HYPOAESTHESIA 1707
49 DRUG HYPERSENSITIVITY 1696
50 PAIN IN EXTREMITY 1691
51 URTICARIA 1673
52 PNEUMONIA 1655
53 COMPLETED SUICIDE 1643
54 DRUG INTERACTION 1549
55 PRODUCT USE ISSUE 1534
56 MOBILITY DECREASED 1521
57 ABDOMINAL PAIN 1520
58 DEATH 1467
59 PERIPHERAL SWELLING 1459
60 MUSCLE SPASMS 1455
61 DISTURBANCE IN ATTENTION 1447
62 JOINT SWELLING 1418
63 SWELLING 1417
64 INCORRECT DRUG ADMINISTRATION DURATION 1387
65 CONTUSION 1385
66 GAIT DISTURBANCE 1368
67 HEPATIC ENZYME INCREASED 1363
68 RHEUMATOID ARTHRITIS 1361
69 DRUG INTOLERANCE 1342
70 CONSTIPATION 1340
71 INFUSION RELATED REACTION 1332
72 ARTHROPATHY 1329
73 GASTROINTESTINAL DISORDER 1328
74 PARAESTHESIA 1325
75 DISCOMFORT 1319
76 MEMORY IMPAIRMENT 1319
77 INJURY 1308
78 BACK PAIN 1307
79 MATERNAL EXPOSURE DURING PREGNANCY 1286
80 MUSCULOSKELETAL STIFFNESS 1284
81 INFECTION 1279
82 ASTHMA 1274
83 GENERAL PHYSICAL HEALTH DETERIORATION 1268
84 STOMATITIS 1241
85 BLOOD CHOLESTEROL INCREASED 1233
86 INTENTIONAL PRODUCT USE ISSUE 1221
87 SLEEP DISORDER 1210
88 FIBROMYALGIA 1204
89 SYSTEMIC LUPUS ERYTHEMATOSUS 1198
90 BLISTER 1194
91 PERICARDITIS 1188
92 TREMOR 1175
93 HAND DEFORMITY 1168
94 DRY MOUTH 1166
95 GLOSSODYNIA 1162
96 LOWER RESPIRATORY TRACT INFECTION 1162
97 PRODUCT DOSE OMISSION ISSUE 1161
98 PEMPHIGUS 1144
99 HELICOBACTER INFECTION 1142
100 DRUG PRESCRIBING ERROR 1115
101 DUODENAL ULCER PERFORATION 1115
102 AGITATION 1100
103 DRUG DEPENDENCE 1095
104 ROAD TRAFFIC ACCIDENT 1087
105 SUICIDAL IDEATION 1086
106 DYSPEPSIA 1081
107 IRRITABLE BOWEL SYNDROME 1079
108 FOLLICULITIS 1078
109 SYNOVITIS 1074
110 WOUND 1074
111 COUGH 1071
112 PSORIATIC ARTHROPATHY 1069
113 OEDEMA 1068
114 HYPOTENSION 1064
115 INCORRECT DOSE ADMINISTERED 1060
116 IMPAIRED HEALING 1057
117 TYPE 2 DIABETES MELLITUS 1052
118 HYPERHIDROSIS 1045
119 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1018
120 TACHYCARDIA 1004
121 TREATMENT FAILURE 1004
122 PRODUCT ADHESION ISSUE 997
123 AGGRESSION 983
124 PALPITATIONS 982
125 LIVER INJURY 980
126 MUSCLE INJURY 967
127 OSTEOARTHRITIS 966
128 PRODUCT SUBSTITUTION ISSUE 965
129 WHEEZING 951
130 BLOOD PRESSURE INCREASED 943
131 MUSCULAR WEAKNESS 934
132 THERAPEUTIC PRODUCT EFFECT DECREASED 929
133 INTENTIONAL PRODUCT MISUSE 923
134 CONTRAINDICATED PRODUCT ADMINISTERED 922
135 LOSS OF CONSCIOUSNESS 908
136 APPLICATION SITE PRURITUS 905
137 ILL-DEFINED DISORDER 901
138 MUSCULOSKELETAL PAIN 872
139 THERAPEUTIC RESPONSE UNEXPECTED 862
140 OEDEMA PERIPHERAL 861
141 IRRITABILITY 857
142 NIGHT SWEATS 847
143 INTENTIONAL OVERDOSE 846
144 PRESCRIBED OVERDOSE 829
145 RHEUMATOID FACTOR POSITIVE 826
146 LOWER LIMB FRACTURE 809
147 AUTOIMMUNE DISORDER 808
148 AMNESIA 800
149 BALANCE DISORDER 797
150 GAIT INABILITY 797
151 THERAPY NON-RESPONDER 789
152 LIVER DISORDER 786
153 EXPOSURE DURING PREGNANCY 781
154 URINARY TRACT INFECTION 771
155 C-REACTIVE PROTEIN ABNORMAL 763
156 ABNORMAL BEHAVIOUR 762
157 SCIATICA 760
158 LUNG DISORDER 755
159 RHEUMATIC FEVER 753
160 DEEP VEIN THROMBOSIS POSTOPERATIVE 752
161 VISION BLURRED 748
162 APPLICATION SITE IRRITATION 746
163 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 740
164 GASTROOESOPHAGEAL REFLUX DISEASE 738
165 HEART RATE INCREASED 735
166 BURSITIS 731
167 CARDIAC ARREST 706
168 SUICIDE ATTEMPT 700
169 DRUG ADMINISTERED AT INAPPROPRIATE SITE 695
170 PSYCHOMOTOR HYPERACTIVITY 679
171 JOINT RANGE OF MOTION DECREASED 678
172 COVID-19 675
173 SWOLLEN JOINT COUNT INCREASED 672
174 INJECTION SITE PAIN 667
175 LIP DRY 667
176 SEIZURE 661
177 ADVERSE DRUG REACTION 659
178 ARTHRITIS 653
179 MEDICATION ERROR 652
180 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 651
181 INFLAMMATION 642
182 VISUAL IMPAIRMENT 642
183 COGNITIVE DISORDER 640
184 ADVERSE EVENT 635
185 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 622
186 OBESITY 609
187 DELIRIUM 604
188 DEPRESSED LEVEL OF CONSCIOUSNESS 603
189 CARDIO-RESPIRATORY ARREST 601
190 MYALGIA 594
191 SEDATION 591
192 APPLICATION SITE PAIN 577
193 HOSPITALISATION 570
194 ILLNESS 568
195 STRESS 567
196 DEHYDRATION 556
197 HALLUCINATION 553
198 ANAEMIA 543
199 ERYTHEMA 538
200 ACUTE KIDNEY INJURY 537
201 CEREBROVASCULAR ACCIDENT 536
202 PULMONARY FIBROSIS 532
203 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 530
204 BRONCHITIS 528
205 FACET JOINT SYNDROME 523
206 UNDERDOSE 521
207 DEPRESSED MOOD 517
208 PERIPHERAL VENOUS DISEASE 515
209 CHEST DISCOMFORT 509
210 FOETAL EXPOSURE DURING PREGNANCY 499
211 ABDOMINAL DISTENSION 489
212 DEVICE DIFFICULT TO USE 485
213 NECK PAIN 483
214 PRODUCT ADMINISTRATION ERROR 475
215 CHILLS 474
216 SLEEP APNOEA SYNDROME 472
217 FEELING HOT 469
218 ANGER 466
219 INFLUENZA 465
220 DISTURBANCE IN SOCIAL BEHAVIOUR 462
221 DRUG EFFECT DECREASED 460
222 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 459
223 THERAPEUTIC RESPONSE DECREASED 459
224 MYOCARDIAL INFARCTION 456
225 WOUND INFECTION 454
226 SURGERY 449
227 WITHDRAWAL SYNDROME 449
228 DYSKINESIA 446
229 FLUSHING 445
230 PULMONARY EMBOLISM 445
231 GRIP STRENGTH DECREASED 444
232 LETHARGY 444
233 UNEVALUABLE EVENT 440
234 SEROTONIN SYNDROME 438
235 EMOTIONAL DISTRESS 437
236 PREGNANCY 434
237 OROPHARYNGEAL PAIN 433
238 DYSPHAGIA 428
239 SYNCOPE 426
240 RENAL FAILURE 424
241 LIVE BIRTH 419
242 CRYING 415
243 RESTLESSNESS 413
244 NERVOUSNESS 411
245 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 410
246 ELECTROCARDIOGRAM QT PROLONGED 409
247 CHRONIC KIDNEY DISEASE 406
248 RESPIRATORY DISORDER 405
249 TREATMENT NONCOMPLIANCE 405
250 PANIC ATTACK 404
251 BREAST CANCER STAGE III 403
252 EAR INFECTION 396
253 RESPIRATORY ARREST 396
254 CROHN^S DISEASE 395
255 HYPERCHOLESTEROLAEMIA 394
256 VERTIGO 392
257 APPLICATION SITE RASH 390
258 PSORIASIS 390
259 TINNITUS 388
260 LUPUS VULGARIS 387
261 PULMONARY OEDEMA 386
262 C-REACTIVE PROTEIN INCREASED 384
263 FEELING JITTERY 378
264 OSTEOPOROSIS 375
265 THERAPY CESSATION 369
266 ULCER HAEMORRHAGE 368
267 RECTAL HAEMORRHAGE 360
268 DRUG WITHDRAWAL SYNDROME 357
269 ACCIDENTAL OVERDOSE 356
270 MULTIPLE SCLEROSIS RELAPSE 355
271 DEVICE ISSUE 354
272 ORTHOSTATIC HYPOTENSION 352
273 PRE-EXISTING CONDITION IMPROVED 352
274 PANCREATITIS 347
275 ACCIDENTAL EXPOSURE TO PRODUCT 345
276 KNEE ARTHROPLASTY 345
277 HIP ARTHROPLASTY 343
278 PRESCRIBED UNDERDOSE 343
279 HAEMOGLOBIN DECREASED 342
280 PSYCHOTIC DISORDER 340
281 NEPHROLITHIASIS 335
282 DISLOCATION OF VERTEBRA 333
283 NEUROPATHY PERIPHERAL 333
284 ATRIAL FIBRILLATION 332
285 UPPER RESPIRATORY TRACT INFECTION 330
286 INFLUENZA LIKE ILLNESS 329
287 PRODUCT ADMINISTRATION INTERRUPTED 328
288 THROMBOCYTOPENIA 327
289 COLITIS ULCERATIVE 326
290 EAR PAIN 326
291 BLOOD CALCIUM DECREASED 322
292 MENTAL DISORDER 321
293 DEVICE BREAKAGE 320
294 SPEECH DISORDER 320
295 HOT FLUSH 317
296 X-RAY ABNORMAL 317
297 COMA 316
298 EMOTIONAL DISORDER 315
299 SEDATION COMPLICATION 315
300 MOOD SWINGS 310
301 DYSGEUSIA 309
302 DEVICE ADHESION ISSUE 308
303 HEPATIC CIRRHOSIS 307
304 POISONING 307
305 EXOSTOSIS 306
306 UNRESPONSIVE TO STIMULI 305
307 SEPSIS 301
308 WHITE BLOOD CELL COUNT INCREASED 299
309 C-REACTIVE PROTEIN 296
310 DEEP VEIN THROMBOSIS 296
311 CREATININE RENAL CLEARANCE DECREASED 294
312 NASAL CONGESTION 294
313 BLOOD GLUCOSE INCREASED 292
314 FLUID RETENTION 292
315 SUBSTANCE ABUSE 292
316 FREQUENT BOWEL MOVEMENTS 287
317 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 287
318 EPISTAXIS 286
319 DRUG EFFECT LESS THAN EXPECTED 285
320 WHITE BLOOD CELL COUNT DECREASED 285
321 HAEMORRHAGE 283
322 LARYNGITIS 283
323 DRY SKIN 281
324 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 280
325 JOINT STIFFNESS 278
326 THROMBOSIS 278
327 FOOT DEFORMITY 277
328 DYSTONIA 276
329 EXPIRED PRODUCT ADMINISTERED 276
330 TIC 276
331 DISABILITY 275
332 NIGHTMARE 274
333 RHABDOMYOLYSIS 273
334 DIABETES MELLITUS 269
335 RASH PRURITIC 268
336 SWELLING FACE 268
337 BONE EROSION 266
338 METABOLIC ACIDOSIS 265
339 BURNING SENSATION 263
340 CONVULSION 261
341 PRODUCT DOSE OMISSION 260
342 DYSARTHRIA 259
343 BRAIN OEDEMA 258
344 MOOD ALTERED 258
345 MYDRIASIS 258
346 BLOOD PRESSURE DECREASED 256
347 HYPOKALAEMIA 256
348 CHOLELITHIASIS 254
349 POOR QUALITY SLEEP 253
350 LIVER FUNCTION TEST INCREASED 252
351 CARDIAC DISORDER 249
352 MULTIPLE SCLEROSIS 246
353 PARANOIA 245
354 URINARY INCONTINENCE 245
355 DRY EYE 244
356 GASTRIC DISORDER 244
357 BRADYCARDIA 243
358 RHINORRHOEA 243
359 BONE PAIN 242
360 ARRHYTHMIA 240
361 MATERNAL EXPOSURE TIMING UNSPECIFIED 239
362 OXYGEN SATURATION DECREASED 239
363 PLATELET COUNT DECREASED 238
364 BODY TEMPERATURE INCREASED 237
365 DRUG LEVEL INCREASED 236
366 MEDICATION OVERUSE HEADACHE 236
367 CATARACT 235
368 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 235
369 CELLULITIS 233
370 DISORIENTATION 233
371 HAEMATOCHEZIA 233
372 DYSPHONIA 231
373 JOINT DISLOCATION 231
374 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 229
375 INJECTION SITE ERYTHEMA 226
376 LUPUS-LIKE SYNDROME 226
377 INJECTION SITE REACTION 225
378 DRUG EFFECT INCOMPLETE 222
379 EYE PAIN 222
380 GASTRIC ULCER 222
381 HYPERSOMNIA 222
382 LABORATORY TEST ABNORMAL 222
383 THERAPEUTIC RESPONSE SHORTENED 221
384 CYSTITIS 220
385 EPILEPSY 220
386 HALLUCINATION, VISUAL 220
387 PRODUCT AVAILABILITY ISSUE 220
388 RED BLOOD CELL SEDIMENTATION RATE INCREASED 219
389 INTENTIONAL SELF-INJURY 218
390 RESPIRATORY FAILURE 217
391 RETINITIS 217
392 NEUTROPENIA 216
393 DRUG TOLERANCE DECREASED 214
394 EDUCATIONAL PROBLEM 214
395 MENTAL STATUS CHANGES 213
396 MUSCLE TWITCHING 212
397 WALKING AID USER 212
398 DRUG-INDUCED LIVER INJURY 211
399 URINARY RETENTION 210
400 APPLICATION SITE SWELLING 209
401 RESPIRATORY DEPRESSION 209
402 ALANINE AMINOTRANSFERASE INCREASED 208
403 HYPOTHYROIDISM 208
404 FLATULENCE 207
405 INTERVERTEBRAL DISC PROTRUSION 206
406 POLLAKIURIA 206
407 SKIN DISCOLOURATION 206
408 APATHY 205
409 AFFECT LABILITY 204
410 HEAD INJURY 204
411 SEASONAL ALLERGY 203
412 SKIN EXFOLIATION 203
413 LIMB INJURY 201
414 ACNE 198
415 INCREASED APPETITE 197
416 GASTROINTESTINAL HAEMORRHAGE 196
417 RESTLESS LEGS SYNDROME 196
418 HERPES ZOSTER 194
419 INJECTION SITE BRUISING 194
420 INITIAL INSOMNIA 193
421 IMPULSIVE BEHAVIOUR 190
422 MANIA 190
423 THROAT IRRITATION 190
424 PORPHYRIA ACUTE 188
425 DRUG DIVERSION 187
426 NEURALGIA 187
427 EXTRA DOSE ADMINISTERED 186
428 HEART RATE DECREASED 184
429 ACUTE MYOCARDIAL INFARCTION 183
430 ASPARTATE AMINOTRANSFERASE INCREASED 183
431 BACK INJURY 182
432 DISEASE RECURRENCE 181
433 PHOTOPHOBIA 181
434 ANAPHYLACTIC REACTION 180
435 PRODUCT PHYSICAL ISSUE 180
436 INTENTIONAL DRUG MISUSE 178
437 PAIN IN JAW 178
438 APHASIA 177
439 BLEPHAROSPASM 177
440 LEUKOPENIA 176
441 ATTENTION DEFICIT HYPERACTIVITY DISORDER 175
442 INTENTIONAL DOSE OMISSION 175
443 RENAL IMPAIRMENT 175
444 HYPOXIA 173
445 PRODUCT STORAGE ERROR 173
446 MOVEMENT DISORDER 172
447 ECZEMA 171
448 FEBRILE NEUTROPENIA 171
449 ULCER 171
450 CARDIAC FAILURE 169
451 BREAST CANCER STAGE II 168
452 DRUG USE DISORDER 168
453 SINUS TACHYCARDIA 168
454 ADHESIVE TAPE USE 167
455 BLOOD POTASSIUM DECREASED 167
456 LIMB DISCOMFORT 167
457 PRODUCTIVE COUGH 166
458 FEAR 165
459 HYPONATRAEMIA 165
460 RETCHING 165
461 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 164
462 FOOT FRACTURE 164
463 SINUS DISORDER 163
464 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 162
465 TRANSIENT ISCHAEMIC ATTACK 162
466 BLOOD CREATININE INCREASED 161
467 BREAST CANCER 161
468 HALLUCINATION, AUDITORY 161
469 IMPAIRED WORK ABILITY 161
470 VIRAL INFECTION 160
471 MENTAL IMPAIRMENT 159
472 DYSURIA 158
473 MUSCLE SPASTICITY 158
474 MIDDLE INSOMNIA 157
475 PLEURAL EFFUSION 157
476 SOMNAMBULISM 155
477 ABORTION SPONTANEOUS 153
478 NAIL DISORDER 153
479 RESPIRATORY TRACT INFECTION 153
480 SKIN DISORDER 153
481 SWOLLEN TONGUE 153
482 BLOOD CREATINE PHOSPHOKINASE INCREASED 152
483 DISEASE PROGRESSION 152
484 DYSSTASIA 152
485 INJECTION SITE PRURITUS 152
486 THROAT TIGHTNESS 152
487 ABNORMAL DREAMS 150
488 HEAD DISCOMFORT 150
489 DRUG SCREEN POSITIVE 149
490 TASTE DISORDER 149
491 THERAPEUTIC PRODUCT INEFFECTIVE 149
492 APPLICATION SITE URTICARIA 148
493 DIPLOPIA 148
494 DELUSION 146
495 THERAPY INTERRUPTED 146
496 DERMATITIS ATOPIC 145
497 DYSPNOEA EXERTIONAL 145
498 GASTRITIS 145
499 HYPOGLYCAEMIA 145
500 SUBSTANCE USE DISORDER 145
501 THERAPEUTIC PRODUCT EFFECT VARIABLE 144
502 COLITIS 143
503 DRUG EFFECT DELAYED 143
504 EYE SWELLING 143
505 HEPATIC STEATOSIS 143
506 INJECTION SITE HAEMORRHAGE 143
507 LOGORRHOEA 143
508 DRUG TOLERANCE 142
509 ENURESIS 142
510 INJECTION SITE SWELLING 142
511 MUSCLE TIGHTNESS 142
512 THINKING ABNORMAL 142
513 ANHEDONIA 141
514 EUPHORIC MOOD 141
515 HUNGER 141
516 CARDIAC FAILURE CONGESTIVE 140
517 IMPAIRED DRIVING ABILITY 140
518 ALTERED STATE OF CONSCIOUSNESS 139
519 BIPOLAR DISORDER 139
520 EYE DISORDER 139
521 EYE IRRITATION 139
522 GRIP STRENGTH 139
523 APPLICATION SITE DISCOLOURATION 138
524 BACK DISORDER 137
525 INFUSION SITE PAIN 137
526 INSURANCE ISSUE 137
527 JOINT INJURY 137
528 DEPENDENCE 136
529 FUNGAL INFECTION 136
530 VAGINAL HAEMORRHAGE 136
531 PNEUMONIA ASPIRATION 135
532 WEIGHT FLUCTUATION 135
533 ANGINA PECTORIS 134
534 BRAIN FOG 132
535 DERMATITIS CONTACT 132
536 FEELING COLD 132
537 PRODUCT DOSE OMISSION IN ERROR 132
538 PULMONARY CONGESTION 132
539 RIB FRACTURE 132
540 PALLOR 131
541 TARDIVE DYSKINESIA 131
542 THIRST 130
543 GENERALISED TONIC-CLONIC SEIZURE 129
544 LIP SWELLING 129
545 ENCEPHALOPATHY 128
546 COELIAC DISEASE 127
547 HAEMATEMESIS 127
548 HYPERGLYCAEMIA 127
549 RASH ERYTHEMATOUS 127
550 HYPOPHAGIA 126
551 PREMATURE BABY 126
552 STAPHYLOCOCCAL INFECTION 125
553 APPLICATION SITE VESICLES 124
554 NERVOUS SYSTEM DISORDER 124
555 RED BLOOD CELL COUNT DECREASED 124
556 SCHIZOAFFECTIVE DISORDER 124
557 CIRCULATORY COLLAPSE 123
558 OCULAR HYPERAEMIA 123
559 SKIN IRRITATION 123
560 LYMPHADENOPATHY 122
561 LACRIMATION INCREASED 121
562 PRODUCT COMPLAINT 121
563 ACCIDENTAL EXPOSURE 119
564 CHOLECYSTITIS CHRONIC 119
565 IMPAIRED GASTRIC EMPTYING 119
566 THERAPEUTIC RESPONSE CHANGED 119
567 BRAIN INJURY 118
568 INCORRECT STORAGE OF DRUG 118
569 RESPIRATORY DISTRESS 118
570 ACTIVITIES OF DAILY LIVING IMPAIRED 117
571 ARTERIOSCLEROSIS CORONARY ARTERY 117
572 CATAPLEXY 117
573 IMPAIRED QUALITY OF LIFE 117
574 ORAL HERPES 117
575 TACHYPNOEA 117
576 BLOOD PRESSURE FLUCTUATION 116
577 CHOKING 116
578 HYPOACUSIS 116
579 RENAL DISORDER 116
580 EYE INJURY 115
581 GALLBLADDER DISORDER 115
582 GASTROENTERITIS VIRAL 115
583 HAEMORRHOIDS 115
584 OBSESSIVE-COMPULSIVE DISORDER 115
585 MAJOR DEPRESSION 114
586 HEPATITIS 113
587 MALIGNANT NEOPLASM PROGRESSION 113
588 BLINDNESS 112
589 CYANOSIS 112
590 EATING DISORDER 112
591 ANKLE FRACTURE 111
592 DRUG EFFECT INCREASED 111
593 SUSPECTED SUICIDE 111
594 APPLICATION SITE BURN 110
595 COORDINATION ABNORMAL 110
596 HAEMATURIA 110
597 PERIPHERAL COLDNESS 110
598 CEREBRAL HAEMORRHAGE 109
599 INCORRECT PRODUCT ADMINISTRATION DURATION 109
600 THERAPY PARTIAL RESPONDER 109
601 EXTRAPYRAMIDAL DISORDER 108
602 POST-TRAUMATIC STRESS DISORDER 108
603 VITAMIN D DEFICIENCY 108
604 ANGIOEDEMA 107
605 BLOOD PRESSURE ABNORMAL 107
606 DEAFNESS 107
607 FEEDING DISORDER 107
608 HEART RATE IRREGULAR 107
609 LIVER FUNCTION TEST ABNORMAL 107
610 SCAR 107
611 BLOOD GLUCOSE DECREASED 106
612 CONCUSSION 106
613 PRESYNCOPE 106
614 RASH MACULAR 106
615 AKATHISIA 105
616 CONGENITAL ANOMALY 105
617 PULMONARY HYPERTENSION 105
618 TOOTH DISORDER 105
619 BLADDER DISORDER 104
620 PRODUCT USE COMPLAINT 104
621 TOOTHACHE 104
622 APPLICATION SITE DRYNESS 103
623 IMMUNODEFICIENCY 103
624 INTESTINAL OBSTRUCTION 103
625 PROCEDURAL PAIN 103
626 PRODUCT INEFFECTIVE 103
627 SKIN BURNING SENSATION 103
628 VISUAL ACUITY REDUCED 103
629 DIVERTICULITIS 102
630 DRUG DOSE OMISSION BY DEVICE 102
631 ORAL PAIN 102
632 SNEEZING 102
633 BRUXISM 101
634 VITAMIN D DECREASED 101
635 ACCIDENT 100
636 FEELING DRUNK 100
637 HIATUS HERNIA 100
638 ONYCHOMADESIS 100
639 TRISMUS 100
640 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 99
641 ERECTILE DYSFUNCTION 99
642 HEMIPARESIS 99
643 KIDNEY INFECTION 99
644 REBOUND EFFECT 99
645 SKIN LESION 99
646 ABDOMINAL PAIN LOWER 98
647 GYNAECOMASTIA 98
648 MUSCULOSKELETAL DISCOMFORT 98
649 PRODUCT DISPENSING ERROR 97
650 CARPAL TUNNEL SYNDROME 96
651 HEPATIC FAILURE 96
652 HERNIA 96
653 INTERVERTEBRAL DISC DEGENERATION 96
654 THYROID DISORDER 96
655 HAEMATOCRIT DECREASED 95
656 MUSCLE RIGIDITY 95
657 PHARMACEUTICAL PRODUCT COMPLAINT 95
658 POISONING DELIBERATE 95
659 ECONOMIC PROBLEM 94
660 HIP FRACTURE 94
661 HYPOKINESIA 94
662 MIOSIS 94
663 PARAESTHESIA ORAL 94
664 SINUS CONGESTION 94
665 SNORING 94
666 SPINAL OSTEOARTHRITIS 94
667 BLOOD ALKALINE PHOSPHATASE INCREASED 93
668 CHROMATURIA 93
669 DEMENTIA 93
670 DEVICE DISLOCATION 93
671 DISSOCIATION 93
672 HEPATOTOXICITY 93
673 NERVE INJURY 93
674 ONYCHOMYCOSIS 93
675 SENSORY DISTURBANCE 93
676 ACUTE RESPIRATORY FAILURE 92
677 AFFECTIVE DISORDER 92
678 ANAL INCONTINENCE 92
679 CARDIAC MURMUR 92
680 COAGULOPATHY 92
681 INFUSION SITE ERYTHEMA 92
682 PRURITUS GENERALISED 92
683 DENTAL CARIES 91
684 DEVICE MALFUNCTION 91
685 EMPHYSEMA 91
686 END STAGE RENAL DISEASE 91
687 FAECES DISCOLOURED 91
688 LYMPHOCYTE COUNT DECREASED 91
689 MYOCARDITIS 90
690 NORMAL NEWBORN 90
691 PRODUCT LABEL CONFUSION 90
692 TUBULOINTERSTITIAL NEPHRITIS 90
693 CARDIAC VALVE DISEASE 89
694 EYE PRURITUS 89
695 RAYNAUD^S PHENOMENON 89
696 SCHIZOPHRENIA 89
697 COLD SWEAT 88
698 OSTEOPENIA 88
699 BLOOD IRON DECREASED 87
700 CARDIOGENIC SHOCK 87
701 CARDIOMEGALY 87
702 DRUG EFFECT VARIABLE 87
703 DRUG EXPOSURE DURING PREGNANCY 86
704 EXPIRED DRUG ADMINISTERED 86
705 GASTRIC HAEMORRHAGE 86
706 LYMPHOEDEMA 86
707 PANIC REACTION 86
708 POST PROCEDURAL COMPLICATION 86
709 SCREAMING 86
710 ADRENAL INSUFFICIENCY 85
711 APNOEA 84
712 BREAST MASS 84
713 CORONARY ARTERY DISEASE 84
714 FOOD ALLERGY 84
715 INFUSION SITE SWELLING 84
716 NARCOLEPSY 84
717 NEOPLASM MALIGNANT 84
718 PRE-ECLAMPSIA 84
719 SKIN ULCER 84
720 HAEMOPTYSIS 83
721 MATERNAL EXPOSURE DURING BREAST FEEDING 83
722 NOCTURIA 83
723 PRODUCT PRESCRIBING ERROR 83
724 RASH GENERALISED 83
725 ACUTE HEPATIC FAILURE 82
726 BEHAVIOUR DISORDER 82
727 FEMUR FRACTURE 82
728 RENAL FUNCTION TEST ABNORMAL 82
729 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 81
730 ACUTE RESPIRATORY DISTRESS SYNDROME 81
731 HAEMATOMA 81
732 INCORRECT ROUTE OF DRUG ADMINISTRATION 81
733 QUALITY OF LIFE DECREASED 81
734 RENAL FAILURE ACUTE 81
735 SPINAL FRACTURE 81
736 SPINAL OPERATION 81
737 ATAXIA 80
738 AUTISM SPECTRUM DISORDER 80
739 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 80
740 HYPOAESTHESIA ORAL 80
741 LEUKOCYTOSIS 80
742 PANCYTOPENIA 80
743 PERSONALITY CHANGE 80
744 SLUGGISHNESS 80
745 TOOTH FRACTURE 80
746 CANDIDA INFECTION 79
747 HYPERKINESIA 79
748 MITRAL VALVE INCOMPETENCE 79
749 PRODUCT TASTE ABNORMAL 79
750 STATUS EPILEPTICUS 79
751 ABASIA 78
752 DRUG ABUSER 78
753 GLAUCOMA 78
754 MATERNAL EXPOSURE BEFORE PREGNANCY 78
755 MYOSITIS 78
756 PAROSMIA 78
757 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 78
758 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 78
759 ROTATOR CUFF SYNDROME 78
760 SWOLLEN JOINT COUNT 78
761 WRIST FRACTURE 78
762 BLOOD URINE PRESENT 77
763 CENTRAL NERVOUS SYSTEM LESION 77
764 HYPERTHERMIA 77
765 MULTIPLE ORGAN DYSFUNCTION SYNDROME 77
766 PELVIC PAIN 77
767 RENAL INJURY 77
768 HYPERREFLEXIA 76
769 MULTIPLE ALLERGIES 76
770 NEUROLEPTIC MALIGNANT SYNDROME 76
771 SKIN HAEMORRHAGE 76
772 TOOTH INFECTION 76
773 ALCOHOL POISONING 75
774 BONE DENSITY DECREASED 75
775 CHOLECYSTECTOMY 75
776 LOCALISED INFECTION 75
777 MYOCLONUS 75
778 PRODUCT FORMULATION ISSUE 75
779 APPLICATION SITE EXFOLIATION 74
780 DECREASED ACTIVITY 74
781 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 74
782 DRUG TOXICITY 74
783 SALIVARY HYPERSECRETION 74
784 STEVENS-JOHNSON SYNDROME 74
785 UPPER LIMB FRACTURE 74
786 BLOOD PRESSURE SYSTOLIC INCREASED 73
787 FACIAL PAIN 73
788 ADVERSE REACTION 72
789 BEDRIDDEN 72
790 BONE DISORDER 72
791 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 72
792 GINGIVAL PAIN 72
793 HEPATIC FUNCTION ABNORMAL 72
794 HEPATOMEGALY 72
795 HOMICIDAL IDEATION 72
796 INCONTINENCE 72
797 INCORRECT PRODUCT STORAGE 72
798 MENORRHAGIA 72
799 MICTURITION URGENCY 72
800 MOTOR DYSFUNCTION 72
801 MUSCULOSKELETAL CHEST PAIN 72
802 OESOPHAGEAL SPASM 72
803 RESPIRATORY TRACT CONGESTION 72
804 APPLICATION SITE REACTION 71
805 DECREASED INTEREST 71
806 INJECTION SITE MASS 71
807 LACTIC ACIDOSIS 71
808 MUSCULOSKELETAL DISORDER 71
809 PANCREATITIS ACUTE 71
810 RHINITIS 71
811 SEPTIC SHOCK 71
812 THERAPEUTIC PRODUCT EFFECT DELAYED 71
813 IRON DEFICIENCY ANAEMIA 70
814 PNEUMONITIS 70
815 TOOTH LOSS 70
816 VENTRICULAR TACHYCARDIA 70
817 ARTERIOSCLEROSIS 69
818 BACTERIAL INFECTION 69
819 INTRACRANIAL PRESSURE INCREASED 69
820 NEUTROPHIL COUNT DECREASED 69
821 PHOTOSENSITIVITY REACTION 69
822 CARDIOMYOPATHY 68
823 CEREBRAL INFARCTION 68
824 EXPOSURE VIA BREAST MILK 68
825 HYPERLIPIDAEMIA 68
826 MOUTH ULCERATION 68
827 PNEUMOTHORAX 68
828 TENDONITIS 68
829 APPETITE DISORDER 67
830 CLOSTRIDIUM DIFFICILE INFECTION 67
831 EYE MOVEMENT DISORDER 67
832 HANGOVER 67
833 HYPERTHYROIDISM 67
834 HYPERTRANSAMINASAEMIA 67
835 INJECTION SITE URTICARIA 67
836 SUPRAVENTRICULAR TACHYCARDIA 67
837 TENDERNESS 67
838 TRANSAMINASES INCREASED 67
839 ASPIRATION 66
840 BLOOD SODIUM DECREASED 66
841 OESOPHAGEAL PAIN 66
842 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 66
843 TEMPERATURE INTOLERANCE 66
844 VENTRICULAR FIBRILLATION 66
845 BODY HEIGHT DECREASED 65
846 HEREDITARY ANGIOEDEMA 65
847 LIGAMENT SPRAIN 65
848 OVARIAN CYST 65
849 PERICARDIAL EFFUSION 65
850 PULMONARY MALFORMATION 65
851 AGEUSIA 64
852 APPLICATION SITE EROSION 64
853 ASCITES 64
854 CARDIOVASCULAR DISORDER 64
855 CYST 64
856 EAR DISCOMFORT 64
857 ERUCTATION 64
858 FINGER DEFORMITY 64
859 FRUSTRATION TOLERANCE DECREASED 64
860 PHARYNGEAL OEDEMA 64
861 APHONIA 63
862 ARTERIOSPASM CORONARY 63
863 CHOREOATHETOSIS 63
864 ECCHYMOSIS 63
865 HYPOPNOEA 63
866 HYSTERECTOMY 63
867 MENSTRUATION IRREGULAR 63
868 NERVE COMPRESSION 63
869 OBSTRUCTIVE SLEEP APNOEA SYNDROME 63
870 ORAL CANDIDIASIS 63
871 ACIDOSIS 62
872 MULTIPLE DRUG THERAPY 62
873 SENSORY LOSS 62
874 SHOCK 62
875 VENTRICULAR EXTRASYSTOLES 62
876 AMENORRHOEA 61
877 BLOOD MAGNESIUM DECREASED 61
878 DERMATITIS 61
879 DERMATITIS ALLERGIC 61
880 FRACTURE 61
881 GOUT 61
882 PRODUCT PRESCRIBING ISSUE 61
883 SEXUAL DYSFUNCTION 61
884 SKIN LACERATION 61
885 ASPHYXIA 60
886 HYPERKALAEMIA 60
887 MALNUTRITION 60
888 OSTEOMYELITIS 60
889 PHARYNGEAL SWELLING 60
890 PHARYNGITIS 60
891 PLATELET COUNT INCREASED 60
892 RASH PAPULAR 60
893 SOCIAL AVOIDANT BEHAVIOUR 60
894 SPINAL DISORDER 60
895 SPONDYLITIS 60
896 SUDDEN DEATH 60
897 TACHYPHRENIA 60
898 TOOTH EXTRACTION 60
899 BLOOD UREA INCREASED 59
900 GRAND MAL CONVULSION 59
901 INJECTION SITE RASH 59
902 LIBIDO DECREASED 59
903 NYSTAGMUS 59
904 SPINAL FUSION SURGERY 59
905 UPPER GASTROINTESTINAL HAEMORRHAGE 59
906 ATELECTASIS 58
907 GASTROENTERITIS 58
908 INCREASED TENDENCY TO BRUISE 58
909 PARKINSON^S DISEASE 58
910 SKIN FISSURES 58
911 CAESAREAN SECTION 57
912 DRUG DISPENSING ERROR 57
913 EXPOSURE VIA INGESTION 57
914 GROWTH RETARDATION 57
915 IMMUNE SYSTEM DISORDER 57
916 PHARYNGITIS STREPTOCOCCAL 57
917 SCOLIOSIS 57
918 SKIN REACTION 57
919 TRICUSPID VALVE INCOMPETENCE 57
920 ADULTERATED PRODUCT 56
921 BLINDNESS UNILATERAL 56
922 BLOOD TRIGLYCERIDES INCREASED 56
923 CORONARY ARTERY DISSECTION 56
924 ENERGY INCREASED 56
925 FORMICATION 56
926 GASTROINTESTINAL PAIN 56
927 HYPOTHERMIA 56
928 MASS 56
929 OVERWEIGHT 56
930 SUICIDAL BEHAVIOUR 56
931 ABSCESS 55
932 ATRIAL SEPTAL DEFECT 55
933 CHOLECYSTITIS 55
934 DEVICE LEAKAGE 55
935 DIZZINESS POSTURAL 55
936 EXPOSURE TO TOXIC AGENT 55
937 GESTATIONAL DIABETES 55
938 MUSCLE STRAIN 55
939 ORAL DISCOMFORT 55
940 PAIN OF SKIN 55
941 PELVIC FRACTURE 55
942 RASH VESICULAR 55
943 STOMACH DISCOMFORT 55
944 TROPONIN INCREASED 55
945 ACCIDENTAL DEATH 54
946 APPENDICITIS 54
947 APPLICATION SITE SCAB 54
948 BRADYPHRENIA 54
949 FACIAL PARALYSIS 54
950 INFUSION SITE PRURITUS 54
951 SUBSTANCE USE 54
952 TENSION 54
953 TORTICOLLIS 54
954 CONJUNCTIVITIS 53
955 HEMIPLEGIA 53
956 INTERNATIONAL NORMALISED RATIO INCREASED 53
957 JAUNDICE 53
958 LOCAL SWELLING 53
959 MIGRAINE WITH AURA 53
960 NEPHROPATHY 53
961 PARALYSIS 53
962 RENAL CYST 53
963 SMALL INTESTINAL OBSTRUCTION 53
964 STRESS CARDIOMYOPATHY 53
965 TUBERCULOSIS 53
966 UTERINE LEIOMYOMA 53
967 ELECTROCARDIOGRAM ABNORMAL 52
968 FOETAL DEATH 52
969 GASTRIC ULCER HAEMORRHAGE 52
970 HYPERPHAGIA 52
971 MULTIPLE DRUG OVERDOSE 52
972 OROPHARYNGEAL DISCOMFORT 52
973 PREMATURE DELIVERY 52
974 PULMONARY MASS 52
975 STREPTOCOCCAL INFECTION 52
976 BLOOD LACTIC ACID INCREASED 51
977 BRONCHIECTASIS 51
978 DEVICE RELATED INFECTION 51
979 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 51
980 HALLUCINATIONS, MIXED 51
981 HYPERACUSIS 51
982 HYPERVENTILATION 51
983 KOUNIS SYNDROME 51
984 NEPHROGENIC ANAEMIA 51
985 OCULAR DISCOMFORT 51
986 RENAL PAIN 51
987 SELF-INJURIOUS IDEATION 51
988 SPINAL PAIN 51
989 SPLENOMEGALY 51
990 ANAPHYLACTIC SHOCK 50
991 DRUG WITHDRAWAL SYNDROME NEONATAL 50
992 EYE HAEMORRHAGE 50
993 PRODUCT PREPARATION ERROR 50
994 PSYCHIATRIC SYMPTOM 50
995 SINUS BRADYCARDIA 50
996 SINUS HEADACHE 50
997 SKIN ABRASION 50
998 TENSION HEADACHE 50
999 DRUG LEVEL DECREASED 49